SCHEMBL28414649

SCHEMBL28414649

CCCOc1ccc(S(=O)(=O)N2CCN(CCCCO)CC2)cc1-c1nc2c(CCC)nn(C)c2c(=S)[nH]1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.70
PDE3B Q13370 4/20 0.69
PDE3A Q14432 4/20 0.69
HDAC1 Q13547 2/20 0.63
HDAC6 Q9UBN7 2/20 0.63
HDAC2 Q92769 1/20 0.63
PDE2A O00408 1/20 0.61
ABCC4 O15439 1/20 0.61
ABCC5 O15440 1/20 0.61
PDE6D O43924 1/20 0.61
PDE8A O60658 1/20 0.61
PDE9A O76083 1/20 0.61
ABCB11 O95342 1/20 0.61
CYP3A4 P08684 1/20 0.61
HTR1A P08908 1/20 0.61
PDE6A P16499 1/20 0.61
PDE6G P18545 1/20 0.61
PDE4A P27815 1/20 0.61
ADORA2A P29274 1/20 0.61
ADORA1 P30542 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716971 0.95 PDE5A (0.76) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6717005 0.93 PDE5A (0.75) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6715686 0.91 PDE5A (0.75) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6713790 0.90 PDE5A (0.85) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6716951 0.90 PDE5A (0.75) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL6719165 0.89 PDE5A (0.74) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6722978 0.89 PDE5A (0.72) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6715673 0.88 PDE5A (0.74) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL6715447 0.88 PDE5A (0.74) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL28414652 0.88 PDE5A (0.62) PDE5APDE3BPDE3APDE2AABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed